
Merck Highlights Breakthroughs in Advanced Cancers and Rare Tumors at ASCO 2025
Merck Unveils Comprehensive Oncology Advances at ASCO 2025, Targeting Advanced Cancers and Rare Tumors Merck, a global leader in science and technology innovation, today announced the presentation of a broad spectrum of new clinical data across more than a dozen…